Clinical Trial Update: Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for kava kava in generalized anxiety disorder; the study has been terminated and no results are reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Generalized Anxiety Disorder

Drugs mentioned

• Kava kava (Piper methysticum)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Anxiety Disorders | Phase 2 | Status: TERMINATED